Characteristic | Group A | Group B | χ 2 | P |
---|---|---|---|---|
(n = 49) | (n = 49) | |||
Gender | ||||
Male | 32 | 35 | 0.425 | 0.514 |
Female | 17 | 14 | ||
KPS | 80.5 ± 2.13 | 81.2 ± 1.71 | 1.794* | 0.076 |
Age (years) | ||||
Median (range) | 54 (38–71) | 52 (40–69) | 1.515* | 0.133 |
Recurrence time (months) | ||||
Median (range) | 11.4 (6–24) | 12.2 (7–23) | 1.978* | 0.051 |
Recurrent tumor size (cm3) | 9.84 ± 3.32 | 10.23 ± 4.13 | 0.515* | 0.608 |
Anatomic recurrence (number) | 11 | 13 | 0.221 | 0.638 |
Postoperative pathological stage | ||||
I + II | 30 | 27 | 0.377 | 0.538 |
III + IV | 19 | 22 | ||
Recurrence of locoregional lymph node metastases (number) | ||||
≤2 | 38 | 40 | 0.251 | 0.616 |
>2 | 11 | 9 |